AILIMITED.NS,0P0001MMRJ,0
AILIMITED · General/Diversified · NSE
₹94
Current Market Price
Fair Value (DCF)
₹26
Margin of Safety
-72.3%
Updated 7h ago
YieldIQ Score
45/100
Piotroski F-Score
5/9
Economic Moat
Narrow
Confidence
24%
ROE
—
Debt/Equity
0.00
WACC
11.1%
Market Cap
₹57 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
—
Return on capital employed
EV / EBITDA
—
Enterprise multiple
Debt / EBITDA
—
Leverage vs earnings
Interest Coverage
—
EBIT covers interest
Current Ratio
—
Short-term liquidity
Asset Turnover
1.31×
Revenue per ₹ of assets
Revenue CAGR (3Y)
25.8%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹94
Bear case
₹13.41
MoS -601.0%
Base case
₹26.04
MoS -261.0%
Bull case
₹36.23
MoS -159.5%
Ratio Trends
Historical ratio trends for AILIMITED are being prepared. Once ready, this section will show multi-year trajectories of ROE, ROCE, margins, leverage, and valuation multiples.
Historical Financials
Historical financials for AILIMITED are being prepared. Check back shortly for a 5-year view of revenue, earnings, cash flow, and balance-sheet trends.
Peer Comparison
Peers not yet ranked for AILIMITED. Comparable companies and side-by-side valuation will appear here once the peer set is established.
Dividend History
No dividend events recorded for AILIMITED in the last 10 years.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of AILIMITED →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for AILIMITED →
Compare
Head-to-head with peers
Compare AILIMITED side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse AILIMITEDNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.